Cyclerion Therapeutics, Inc. (CYCN) Dividend History

Cyclerion Therapeutics, Inc. (CYCN) is a clinical-stage biotechnology company focused on developing innovative therapies for cognitive and neurological disorders. The company leverages its neuroscience platform to identify and advance novel compounds aimed at enhancing cognitive function and treating serious neurological conditions.

301 Binney Street, Cambridge, MA, 02142
Phone: 617-621-7722
Website:

Dividend History

Cyclerion Therapeutics, Inc. currently does not pay dividends

Company News

  • – Asset Purchase Agreement Closed; Cyclerion Received Equity Ownership in Tisento and Upfront Cash Payment –

    GlobeNewswire Inc.
  • CAMBRIDGE, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (“Cyclerion” or the “Company”) (Nasdaq: CYCN) today announced that it has received a formal notice from The Nasdaq Stock Market (Nasdaq) stating that Cyclerion has regained compliance with the $1.00 per share minimum bid price requirement pursuant to Nasdaq Listing Rule 5550(a)(2), and that Cyclerion is in compliance with all applicable listing standards.

    GlobeNewswire Inc.
  • Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. The Singing Machine Company, Inc. (NASDAQ: MICS) surged 73% to $1.81 after the company announced termination of its at-the-market equity program. Applied Digital Corporation (NASDAQ: APLD) gained 44.6% to $4.94 after the company announced that its recently launched AI Cloud Service has secured its first major AI customer with an agreement worth up to $180 million over a 24-month period. OncoSec Medical Incorporated (NASDAQ: ONCS) jumped 30% to $1.08. OncoSec said Type C meeting with the FDA was held on May 15. Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) gained 27.6% to $4.88. Cyclerion reported a 1-for-20 reverse stock split, effective 5 p.m. on May 15. Phio Pharmaceuticals Corp. (NASDAQ: PHIO) jumped 24.4% to $4.18 after the company announced the FDA cleared its Investigational New Drug application to proceed with a clinical trial of its lead product candidate, PH-762. Blue Apron Holdings, Inc. (NYSE: APRN) jumped 25% to $0.5726. Blue Apron announced plans to shift to an asset-light model through the transfer of operational infrastructure to FreshRealm. VivoPower International PLC (NASDAQ: VVPR) shares gained 21.3% to $0.5631 after the company announced a definitive distribution agreement to distribute EV fleet charging solutions. Navitas Semiconductor Corporation (NASDAQ: NVTS) jumped 18.8% to $7.89 after the company reported better-than-expected Q1 financial results. Atlas Lithium Corporation (NASDAQ: ATLX) shares gained 18% to $22.39. United Insurance Holdings Corp. (NASDAQ: UIHC) gained 17.8% to $4.82 after posting a profit for the first quarter. Troika Media Group, Inc. (NASDAQ: TRKA) jumped 17.7% to $0.2328 after the company reported revenue of $59.0 million and adjusted EBITDA of $1.5 million for the three months ended March 31, 2023. ASP Isotopes Inc. (NASDAQ: ASPI) shares gained 16.3% to $0.51 after declining around 7% on Monday. Troika Media Group, Inc. (NASDAQ: TRKA) shares rose 16.3% to $0.2302 after the company reported a rise in third-quarter sales. Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) gained 15.8% to $10.09. Top KingWin Ltd (NASDAQ: TCJH) gained 15% to $7.34. Nanobiotix S.A. (NASDAQ: NBTX) rose 13.2% to $5.31. Nanobiotix recently announced it is entering into final contract negotiations after agreement to a non-binding term ...

    Benzinga
  • CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (the “Company”, “Cyclerion Therapeutics”, “Cyclerion”) (Nasdaq: CYCN) announced today that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20, effective as of 5:00 p.m. Eastern Time on May 15, 2023. The reverse stock split was approved by the Company’s stockholders at its annual meeting of stockholders held on May 15, 2023, with the final ratio determined by the Company’s board of directors.

    GlobeNewswire Inc.
  • Definitive agreement reached with new company (“NewCo”) established by certain Cyclerion shareholders and new investors

    GlobeNewswire Inc.
Dividend data last updated 06/06/2025 22:25:55 UTC